atenolol has been researched along with flunarizine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruno-Blanch, L; Gálvez, J; García-Domenech, R | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Brotzu, G; Falchi, S; Mannu, B; Montisci, R; Petruzzo, P; Staico, R | 1 |
| Henry, P | 1 |
| Yu, L; Zeng, S | 1 |
| Jevoux, C; Krymchantowski, AV | 1 |
| Jevoux, C; Krymchantowski, AV; Moreira, PF | 1 |
| Almeida, KJ; Bernardino, SN; Silva-Néto, RP | 1 |
2 trial(s) available for atenolol and flunarizine
| Article | Year |
|---|---|
The importance of presynaptic beta receptors in Raynaud's disease.
Topics: Adolescent; Adult; Atenolol; Clinical Trials as Topic; Drug Therapy, Combination; Female; Flunarizine; Humans; Male; Middle Aged; Plethysmography; Random Allocation; Raynaud Disease; Receptors, Adrenergic, beta | 1989 |
Analysis of the duration of migraine prophylaxis.
Topics: Adolescent; Adult; Atenolol; Dose-Response Relationship, Drug; Female; Flunarizine; Humans; International Classification of Diseases; Male; Middle Aged; Migraine Disorders; Nortriptyline; Prospective Studies; Time Factors; Treatment Outcome; Vasodilator Agents; Young Adult | 2014 |
6 other study(ies) available for atenolol and flunarizine
| Article | Year |
|---|---|
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
Topics: Anticonvulsants; Computer Simulation; Databases, Factual; Discriminant Analysis; Drug Design; Molecular Structure; Quantitative Structure-Activity Relationship | 2003 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
[Migraine: a disease, not a symptom].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Analgesics; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Atenolol; Diagnosis, Differential; Dihydroergotamine; Flunarizine; GABA Agents; Humans; Indoramin; Methysergide; Migraine Disorders; Oxazolidinones; Serotonin Antagonists; Serotonin Receptor Agonists; Tryptamines; Valproic Acid; Vasoconstrictor Agents; Vasodilator Agents | 2002 |
Transport characteristics of zolmitriptan in a human intestinal epithelial cell line Caco-2.
Topics: Aspirin; Atenolol; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Biological Transport; Caco-2 Cells; Cetirizine; Cimetidine; Diffusion; Dose-Response Relationship, Drug; Drug Interactions; Flunarizine; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Intestinal Mucosa; Oxazolidinones; Permeability; Propranolol; Serotonin Receptor Agonists; Sodium-Hydrogen Exchangers; Tryptamines | 2007 |
Quetiapine for the prevention of migraine refractory to the combination of atenolol + nortriptyline + flunarizine: an open pilot study.
Topics: Adult; Antipsychotic Agents; Atenolol; Dibenzothiazepines; Drug Resistance; Drug Therapy, Combination; Female; Flunarizine; Humans; Male; Middle Aged; Migraine Disorders; Nortriptyline; Pilot Projects; Prospective Studies; Quetiapine Fumarate; Treatment Outcome; Young Adult | 2008 |
An open pilot study assessing the benefits of quetiapine for the prevention of migraine refractory to the combination of atenolol, nortriptyline, and flunarizine.
Topics: Adrenergic beta-Antagonists; Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Atenolol; Calcium Channel Blockers; Dibenzothiazepines; Drug Resistance; Drug Therapy, Combination; Female; Flunarizine; Follow-Up Studies; Humans; Male; Middle Aged; Migraine Disorders; Nortriptyline; Pilot Projects; Quetiapine Fumarate; Treatment Outcome; Young Adult | 2010 |